These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 1659156)
1. Linoleic acid and dihomogammalinolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of antiinflammatory compounds. Iversen L; Fogh K; Bojesen G; Kragballe K Agents Actions; 1991 Jul; 33(3-4):286-91. PubMed ID: 1659156 [TBL] [Abstract][Full Text] [Related]
2. Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway. Iversen L; Fogh K; Kragballe K Arch Dermatol Res; 1992; 284(4):222-6. PubMed ID: 1329675 [TBL] [Abstract][Full Text] [Related]
3. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils. Fogh K; Herlin T; Kragballe K Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922 [TBL] [Abstract][Full Text] [Related]
5. Metabolism of gammalinolenic acid in human neutrophils. Chilton-Lopez ; Surette ME; Swan DD; Fonteh AN; Johnson MM; Chilton FH J Immunol; 1996 Apr; 156(8):2941-7. PubMed ID: 8609415 [TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase. Profita M; Sala A; Siena L; Henson PM; Murphy RC; PaternĂ² A; Bonanno A; Riccobono L; Mirabella A; Bonsignore G; Vignola AM J Pharmacol Exp Ther; 2002 Mar; 300(3):868-75. PubMed ID: 11861792 [TBL] [Abstract][Full Text] [Related]
7. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes. Wainwright S; Falck JR; Yadagiri P; Powell WS Biochemistry; 1990 Oct; 29(43):10126-35. PubMed ID: 2176862 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of ionophore-stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids. Camp RD; Fincham NJ Br J Pharmacol; 1985 Aug; 85(4):837-41. PubMed ID: 2994785 [TBL] [Abstract][Full Text] [Related]
10. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites. Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro. Fogh K; Larsen CG; Iversen L; Kragballe K Agents Actions; 1992 Mar; 35(3-4):227-31. PubMed ID: 1529797 [TBL] [Abstract][Full Text] [Related]
13. 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity. Gagnon KJ; Lefort N; Poirier SJ; Barnett DA; Surette ME Prostaglandins Leukot Essent Fatty Acids; 2018 Nov; 138():38-44. PubMed ID: 30392579 [TBL] [Abstract][Full Text] [Related]
14. Activation of the human neutrophil 5-lipoxygenase by leukotriene B4. McDonald PP; McColl SR; Naccache PH; Borgeat P Br J Pharmacol; 1992 Sep; 107(1):226-32. PubMed ID: 1330161 [TBL] [Abstract][Full Text] [Related]
15. Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate. Sperling RI; Benincaso AI; Anderson RJ; Coblyn JS; Austen KF; Weinblatt ME Arthritis Rheum; 1992 Apr; 35(4):376-84. PubMed ID: 1314609 [TBL] [Abstract][Full Text] [Related]
16. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Betts WH; Hurst NP; Murphy GA; Cleland LG Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444 [TBL] [Abstract][Full Text] [Related]
17. Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat. Fischer DB; Christman JW; Badr KF Kidney Int; 1992 May; 41(5):1155-60. PubMed ID: 1319518 [TBL] [Abstract][Full Text] [Related]
18. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway. Liles WC; Meier KE; Henderson WR J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073 [TBL] [Abstract][Full Text] [Related]
19. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. Williams JD; Lee TH; Lewis RA; Austen F J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947 [TBL] [Abstract][Full Text] [Related]
20. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells. Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]